Same medicine. Same results.
Lower cost.

Trade Agreements

GPhA Position

Agreements between the U.S. and its trade partners should maintain a reasonable balance between protecting intellectual property that incentivizes innovation of new medicines and supporting access to more affordable generics. GPhA will continue to advocate for provisions that support consumer access to affordable generic medicines and promote competition. 

GPhA Efforts

  • GPhA advocates for trade agreements that promote competition and support access to medicines.

  • GPhA monitors and engages with negotiators for the Trans-Pacific Partnership (TPP) and the Trans-Atlantic Trade and Investment Partnership (TTIP) in close consultation with its membership, foreign counterpart associations, the International Global Pharmaceutical Alliance (IGPA) and strategic allies. 


Press Releases


Related Information